Assistant Professor @VUMCHemOnc | Co-Host @TheFellowOnCall | Alum of @VUMCMedicineRes @VUMedicine @dukeu | #meded #cancer | Tweets my own
Nashville, TN
Joined January 2022
- Tweets312
- Following197
- Followers917
- Likes1.2K
Pinned Tweet
Hey #medtwitter
Here are the basics on unequal randomization in trials
Why should we do 1:1 instead of 2:1 or 3:1 in phase 3 RCTs?
🧵
Vivek Patel, MD retweeted
🚨Hot off the press: A simultaneous publication in @JCOOP_ASCO alongside @vpatelmd’s presentation highlighting the 1st cluster randomized study evaluating podcasts for heme/onc education!
The outcome: @TheFellowOnCall and @TwoOncDocs should be included for h/o fellow education!
Conquer cancer awardee Morgan Zenner @VUMC_Medicine
Multicenter analysis of the impact of late ICAHT after CART for large B cell lymphoma
Not associated with severe infection or survival outcomes. Stop by poster 24 to learn more!
Thanks to Peter Reidell @UCCancerCenter
Really proud of two of my mentees receiving @ConquerCancerFd merit awards!
Ronak Mistry for our innovative heme/onc med ed research and Morgan Zenner for our work in CART
@CathyEngMD @VUMC_Medicine @jordanberlin5 @benhopark @VUMCMedicineRes @rmistry91
Congratulations to this year's class of Conquer Cancer Grant and Award recipients! We can't wait to celebrate with you at #ASCO24! Full list of recipients: brnw.ch/21wKdIf
Vivek Patel, MD retweeted
🧵THE FELLOW ON CALL TWEETORIAL SERIES 🧵
1/ APPROACH TO ANEMIA👇
🎧Spotify: shorturl.at/zBMNZ
🍎Apple: shorturl.at/txFMP
Website: shorturl.at/dkFL7
Vivek Patel, MD retweeted
Receiving emails like this 💯
Thanks to all our listeners! We’re so excited to be on this journey with you!
Vivek Patel, MD retweeted
Here are my slides on a talk I gave on why there is no association between most auto-immune diseases and MGUS.
And why previous studies were flawed/claimed erroneous associations.
All credit to the amazing @iStopMM for this.
tinyurl.com/ky9smm3e
@SarahSchaferMD
#mmsm
Vivek Patel, MD retweeted
Time for another "Heme Consult Series," this time focusing on the dx and mgmt of von Willebrand Disease! This week, in pt 1, we break down the approach to dx and discuss Types 1 and 3.
Many find vWD mgmt confusing, but don't worry - we got you covered 😎
Link in bio!
Vivek Patel, MD retweeted
Daratumumab has been known to be effective in relapsed myeloma for a long time.
Yet it was mostly not given to the control arm upon progression in trials of newly diagnosed myeloma.
This is a preventable tragedy- that we must avoid repeating.
#mmsm
jamanetwork.com/journals/jam…
Vivek Patel, MD retweeted
This week, it's all about early stage triple negative breast cancer! As always, we cover the highlights of the disease and how we got to our current treatment landscape.
This episode also rounds out our early stage discussions - next up: metastatic disease
Link in bio! #BCSM
Vivek Patel, MD retweeted
Excited to see my perspective piece in @NEJM re:“hospital problems”
Have a read & thanks to all who have shared already!
nejm.org/doi/full/10.1056/NE…
Vivek Patel, MD retweeted
Ep. 2 of our collab with our friends @TwoOncDocs is now available! This time, we talk about the SWOG 1826 plenary from #ASCO23, define p-values, trial medians, the pros/cons of the trial & how this informs our mgmt of Hodgkin's lymphoma! Check it out here: podcasts.apple.com/us/podcas…
Episode 1 of our collab with our friends @TwoOncDocs is now available! We talk all about the #PROSPECT Trial discussed at #ASCO23, what a "non-inferiority trial" really is, pros/cons of the study, & how this informs our mgmt! Check it out here: podcasts.apple.com/us/podcas…
Vivek Patel, MD retweeted
Episode 1 of our collab with our friends @TwoOncDocs is now available! We talk all about the #PROSPECT Trial discussed at #ASCO23, what a "non-inferiority trial" really is, pros/cons of the study, & how this informs our mgmt! Check it out here: podcasts.apple.com/us/podcas…
We are SO EXCITED to be teaming up with our friends @TwoOncDocs for a special upcoming series this month following #ASCO23!
To learn more about this Collaborative Series, check out our teaser: podcasts.apple.com/us/podcas…
Stay tuned, y'all! This is going to be 🔥!
We had a great conversation with @kaydaustin at ASCO. Amazing patient advocate and looking forward to working on a few initiatives with her. Check out her story and listen to her podcast to get important insights from a patient perspective. @rmistry91
What's it like being a once shy and very introverted patient advocate at the largest oncology conference?
A thread on #ASCO23 from a patient perspective and a heartfelt thank you to those who truly embodied ASCO's theme this year - Partnering with Patients 👇
Vivek Patel, MD retweeted
We are SO EXCITED to be teaming up with our friends @TwoOncDocs for a special upcoming series this month following #ASCO23!
To learn more about this Collaborative Series, check out our teaser: podcasts.apple.com/us/podcas…
Stay tuned, y'all! This is going to be 🔥!
Vivek Patel, MD retweeted
Time for part ✌️of our early stage ER+ #breastcancer discussion! Let's round our great discussion, focusing on more high yield topics you need to know to care for your patients (& for exams!)
#ICYMI highly recommend checking out episode 057 first!
Link in bio! #BCSM #ASCO23
Vivek Patel, MD retweeted
After several weeks of some amazing discussions with our special guests, it's time to chat about the role of #medonc in the management of #BreastCancer! First up, we start our discussion on early stage ER+ breast cancer.
Trust us, this is a good one, y'all! #bcsm
Vivek Patel, MD retweeted
Calling all physicians/advanced practice providers seeing pts with multiple myeloma!
We invite you to participate in a quick survey on "Clinician Perspectives on Smoldering Myeloma."
Led by @bdermanmd @rajshekharucms @Eddie_Cliff
Survey link: bit.ly/smolderingMM
#mmsm
Vivek Patel, MD retweeted
Pharmacists play a critical role in the care of our patients. This week, we welcome our special guest Dr. Danielle Roman, PharmD who helps us navigate breast cancer pharmacology
Check out the show notes at our website for high yield info! Link in bio! #BCSM
